Manacap, Manacap L.
HRN: 21-73-00 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/10/2022
METRONIDAZOLE 500MG (TAB)
08/10/2022
08/16/2022
ORAL
500mg
TID
Incomplete Abortion
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes